The most common and widely accepted classification of breast cancer is from an immunohistochemical perspective and is based on the expression of the following hormone receptors: estrogen (ER), progesterone (PR), and human epidermal growth factor 2 (HER2). This evidence concerns the gene ERBB2 and breast cancer.